The impact of Nrf2 on the sensitivity of anaplastic thyroid cancer cells to lenvatinib was also investigated to evaluate its potential clinical implication. The gene discussed is NFE2L2; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.